Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600120062) titled 'Effect of Efsubaglutide Alfa combined with dietary fiber intervention on body weight in overweight/obese patients with polycystic ovary syndrome (PCOS), A multi-center randomized controlled study' on March 9.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Shanghai General Hospital
Condition:
Polycystic ovary syndrome, Overweight/obesity
Intervention:
Efsubaglutide a group:Efsubaglutide a 3 mg by subcutaneous injection once weekly
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-03-31
Target Sample Size: Efsubaglutide a group:30;Efsubaglutid...